SEC Form 4 · accession 0001127602-18-035830
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 11, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2018 | M | 900 | $52.65 | A | 4,270 | D | |
| Common StockF1 | Dec 11, 2018 | D | 900 | $111.00 | D | 3,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Dec 11, 2018 | M | 900 | D | Jan 1, 2011 | Jan 1, 2020 | Common Stock | 900 | 17,100 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $111.00 to $111.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.